ID   APOE_MACMU              Reviewed;         295 AA.
AC   Q28502; G7NMA9;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   11-DEC-2019, sequence version 2.
DT   07-APR-2021, entry version 115.
DE   RecName: Full=Apolipoprotein E;
DE            Short=Apo-E;
DE   Flags: Precursor;
GN   Name=APOE;
OS   Macaca mulatta (Rhesus macaque).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini;
OC   Cercopithecidae; Cercopithecinae; Macaca.
OX   NCBI_TaxID=9544;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=22002653; DOI=10.1038/nbt.1992;
RA   Yan G., Zhang G., Fang X., Zhang Y., Li C., Ling F., Cooper D.N., Li Q.,
RA   Li Y., van Gool A.J., Du H., Chen J., Chen R., Zhang P., Huang Z.,
RA   Thompson J.R., Meng Y., Bai Y., Wang J., Zhuo M., Wang T., Huang Y.,
RA   Wei L., Li J., Wang Z., Hu H., Yang P., Le L., Stenson P.D., Li B., Liu X.,
RA   Ball E.V., An N., Huang Q., Zhang Y., Fan W., Zhang X., Li Y., Wang W.,
RA   Katze M.G., Su B., Nielsen R., Yang H., Wang J., Wang X., Wang J.;
RT   "Genome sequencing and comparison of two nonhuman primate animal models,
RT   the cynomolgus and Chinese rhesus macaques.";
RL   Nat. Biotechnol. 29:1019-1023(2011).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 70-176.
RX   PubMed=8635577; DOI=10.1016/0014-5793(95)01491-8;
RA   Morelli L., Wei L., Amorim A., McDermid J., Abee C.R., Frangione B.,
RA   Walker L.C., Levy E.;
RT   "Cerebrovascular amyloidosis in squirrel monkeys and rhesus monkeys:
RT   apolipoprotein E genotype.";
RL   FEBS Lett. 379:132-134(1996).
CC   -!- FUNCTION: APOE is an apolipoprotein, a protein associating with lipid
CC       particles, that mainly functions in lipoprotein-mediated lipid
CC       transport between organs via the plasma and interstitial fluids. APOE
CC       is a core component of plasma lipoproteins and is involved in their
CC       production, conversion and clearance. Apoliproteins are amphipathic
CC       molecules that interact both with lipids of the lipoprotein particle
CC       core and the aqueous environment of the plasma. As such, APOE
CC       associates with chylomicrons, chylomicron remnants, very low density
CC       lipoproteins (VLDL) and intermediate density lipoproteins (IDL) but
CC       shows a preferential binding to high-density lipoproteins (HDL). It
CC       also binds a wide range of cellular receptors including the LDL
CC       receptor/LDLR, the LDL receptor-related proteins LRP1, LRP2 and LRP8
CC       and the very low-density lipoprotein receptor/VLDLR that mediate the
CC       cellular uptake of the APOE-containing lipoprotein particles. Finally,
CC       APOE has also a heparin-binding activity and binds heparan-sulfate
CC       proteoglycans on the surface of cells, a property that supports the
CC       capture and the receptor-mediated uptake of APOE-containing
CC       lipoproteins by cells. A main function of APOE is to mediate
CC       lipoprotein clearance through the uptake of chylomicrons, VLDLs, and
CC       HDLs by hepatocytes. APOE is also involved in the biosynthesis by the
CC       liver of VLDLs as well as their uptake by peripheral tissues ensuring
CC       the delivery of triglycerides and energy storage in muscle, heart and
CC       adipose tissues. By participating in the lipoprotein-mediated
CC       distribution of lipids among tissues, APOE plays a critical role in
CC       plasma and tissues lipid homeostasis. APOE is also involved in two
CC       steps of reverse cholesterol transport, the HDLs-mediated transport of
CC       cholesterol from peripheral tissues to the liver, and thereby plays an
CC       important role in cholesterol homeostasis. First, it is functionally
CC       associated with ABCA1 in the biogenesis of HDLs in tissues. Second, it
CC       is enriched in circulating HDLs and mediates their uptake by
CC       hepatocytes. APOE also plays an important role in lipid transport in
CC       the central nervous system, regulating neuron survival and sprouting.
CC       {ECO:0000250|UniProtKB:P02649}.
CC   -!- SUBUNIT: Homotetramer. May interact with ABCA1; functionally associated
CC       with ABCA1 in the biogenesis of HDLs. May interact with APP/A4 amyloid-
CC       beta peptide; the interaction is extremely stable in vitro but its
CC       physiological significance is unclear. May interact with MAPT. May
CC       interact with MAP2. In the cerebrospinal fluid, interacts with secreted
CC       SORL1. {ECO:0000250|UniProtKB:P02649}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P02649}.
CC       Secreted, extracellular space {ECO:0000250|UniProtKB:P02649}. Secreted,
CC       extracellular space, extracellular matrix
CC       {ECO:0000250|UniProtKB:P02649}. Note=In the plasma, APOE is associated
CC       with chylomicrons, chylomicrons remnants, VLDL, LDL and HDL
CC       lipoproteins. Lipid poor oligomeric APOE is associated with the
CC       extracellular matrix in a calcium- and heparan-sulfate proteoglycans-
CC       dependent manner. Lipidation induces the release from the extracellular
CC       matrix. {ECO:0000250|UniProtKB:P02649}.
CC   -!- PTM: APOE exists as multiple glycosylated and sialylated glycoforms
CC       within cells and in plasma. The extent of glycosylation and sialylation
CC       are tissue and context specific. {ECO:0000250|UniProtKB:P02649}.
CC   -!- PTM: Glycated in plasma VLDL. {ECO:0000250|UniProtKB:P02649}.
CC   -!- PTM: Phosphorylated by FAM20C in the extracellular medium.
CC       {ECO:0000250|UniProtKB:P02649}.
CC   -!- SIMILARITY: Belongs to the apolipoprotein A1/A4/E family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CM001271; EHH30133.1; -; Genomic_DNA.
DR   EMBL; U52030; AAC50441.1; -; mRNA.
DR   SMR; Q28502; -.
DR   STRING; 9544.ENSMMUP00000018786; -.
DR   eggNOG; ENOG502QVD6; Eukaryota.
DR   HOGENOM; CLU_066029_0_1_1; -.
DR   InParanoid; Q28502; -.
DR   OMA; ARLKGWF; -.
DR   Proteomes; UP000006718; Unplaced.
DR   Proteomes; UP000013456; Chromosome 19.
DR   GO; GO:0042627; C:chylomicron; IEA:UniProtKB-KW.
DR   GO; GO:0031012; C:extracellular matrix; ISS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0034364; C:high-density lipoprotein particle; ISS:UniProtKB.
DR   GO; GO:0034363; C:intermediate-density lipoprotein particle; ISS:UniProtKB.
DR   GO; GO:0034362; C:low-density lipoprotein particle; ISS:UniProtKB.
DR   GO; GO:0034361; C:very-low-density lipoprotein particle; ISS:UniProtKB.
DR   GO; GO:0001540; F:amyloid-beta binding; IBA:GO_Central.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; ISS:UniProtKB.
DR   GO; GO:0008201; F:heparin binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0050750; F:low-density lipoprotein particle receptor binding; ISS:UniProtKB.
DR   GO; GO:0070326; F:very-low-density lipoprotein particle receptor binding; IBA:GO_Central.
DR   GO; GO:0006707; P:cholesterol catabolic process; IBA:GO_Central.
DR   GO; GO:0033344; P:cholesterol efflux; ISS:UniProtKB.
DR   GO; GO:0034382; P:chylomicron remnant clearance; ISS:UniProtKB.
DR   GO; GO:0034380; P:high-density lipoprotein particle assembly; ISS:UniProtKB.
DR   GO; GO:0071831; P:intermediate-density lipoprotein particle clearance; ISS:UniProtKB.
DR   GO; GO:0042158; P:lipoprotein biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0042159; P:lipoprotein catabolic process; IBA:GO_Central.
DR   GO; GO:1905907; P:negative regulation of amyloid fibril formation; ISS:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IBA:GO_Central.
DR   GO; GO:0031175; P:neuron projection development; ISS:UniProtKB.
DR   GO; GO:1900223; P:positive regulation of amyloid-beta clearance; ISS:UniProtKB.
DR   GO; GO:0051000; P:positive regulation of nitric-oxide synthase activity; IBA:GO_Central.
DR   GO; GO:1900221; P:regulation of amyloid-beta clearance; IBA:GO_Central.
DR   GO; GO:0071830; P:triglyceride-rich lipoprotein particle clearance; ISS:UniProtKB.
DR   GO; GO:0034447; P:very-low-density lipoprotein particle clearance; ISS:UniProtKB.
DR   InterPro; IPR000074; ApoA_E.
DR   Pfam; PF01442; Apolipoprotein; 1.
PE   2: Evidence at transcript level;
KW   Chylomicron; Extracellular matrix; HDL; Heparin-binding; Lipid transport;
KW   Lipid-binding; Oxidation; Phosphoprotein; Reference proteome; Repeat;
KW   Secreted; Signal; Transport; VLDL.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..295
FT                   /note="Apolipoprotein E"
FT                   /id="PRO_0000191637"
FT   REPEAT          80..101
FT                   /note="1"
FT   REPEAT          102..123
FT                   /note="2"
FT   REPEAT          124..145
FT                   /note="3"
FT   REPEAT          146..167
FT                   /note="4"
FT   REPEAT          193..211
FT                   /note="5"
FT   REPEAT          212..233
FT                   /note="6"
FT   REGION          80..233
FT                   /note="6 X 22 AA approximate tandem repeats"
FT   REGION          158..168
FT                   /note="LDL and other lipoprotein receptors binding"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   REGION          162..165
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   REGION          191..268
FT                   /note="Lipid-binding and lipoprotein association"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   REGION          244..295
FT                   /note="Homooligomerization"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   REGION          256..268
FT                   /note="Specificity for association with VLDL"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   MOD_RES         143
FT                   /note="Methionine sulfoxide"
FT                   /evidence="ECO:0000250|UniProtKB:P08226"
FT   MOD_RES         147
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
SQ   SEQUENCE   295 AA;  33563 MW;  8312386F1291F3E4 CRC64;
     MKVLWAALLV TFLAGCQAKV EQPVEPETEP ELRQQAEGQS GQPWELALGR FWDYLRWVQT
     LSEQVQEELL SPQVTQELTT LMDETMKELK AYKSELEEQL SPVAEETRAR LSKELQAAQA
     RLGADMEDVR SRLVQYRSEV QAMLGQSTEE LRARLASHLR KLRKRLLRDA DDLQKRLARL
     GPLVEQGRVR AATVGSLASQ PLQERAQAKL RARMEEMGSR TRDRLDEVKE QVAEVRAKLE
     EQAQQISLQA EAFQARLKSW FEPLVEDMQR QWAGLVEKVQ AAVGASTAPV PSDNH
//
